Skip to content
★ Sign in to follow
i-SENS, Inc. logo

i-SENS, Inc. Stock: price and insider trades · South Korea

아이센스

KR·Mcap ₩470.7BHealth Care

No insider purchase over the last 90 days. The latest, by 남학현, was filed 24 Jun 2026.

i-SENS, Inc.: what insiders have been doing

i-SENS, Inc. is a Health Care company. Its directors and officers file their transactions with DART (FSS). From 9 November 2025 to 9 November 2026, the disclosure feed for i-SENS, Inc. logged 7 filings by 1 insider.

Only purchases show up on the open market, 7 purchases in all worth €9,993, filed by 1 insider. The totals do not cover 6 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Biggest ticket of the year: €9,993, bought by 남학현 and made public on 1 June 2026. Those buying include 1 chief executive.

Compared with its exchange (2,630 companies, median 7 filings), a count of 7 filings is typical. Our records for i-SENS, Inc. go back to 2021, with 30 purchases and 22 sales on the open market in total.

The last insider purchase was made public on 21 July 2026, 111 days ago.

Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.

Insider Decl.
72
Thresholds
n/a
Buy Volume
€9,993
30 ops. · all time
Sell Volume
n/a
22 ops. · all time

Who traded when

BuySale
남학현8 buys
차근식1 buy2 sales
아크레이2 buys
안상도1 sale

Since the insiders bought

  • Filed 01 Jun 2026 · 161 days ago · €9,993
    +7.3%
    Entry ₩16,800 · Close at T+90 ₩18,030

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 23,398 of 26,913 companies
24.9
score / 100
Value
21
Quality
29
FCF yld-2.4%
Earn yld-1.5%
EV/EBITDA38.2x
ROE·
Gross mgn40%
Net mgn-1.6%
Debt/EBITDA12.7x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩16,370
Analyst consensus
2 analysts
·
₩32,000Target ₩36,000(+120%)₩40,000
Income statement
Revenue₩315.4B
Gross profit₩125.3B40% margin
EBITDA₩13.7B4% margin
Net income-₩5.1B-1.6% margin
Balance sheet & cash
Market cap₩470.7B
Total debt₩173.8B
Free Cash Flow-₩8.3B
Last declaration on 30 June 2026
Declarations75 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ●
    Executives(filed)
    0DART
    ShareKRXDART:20260630000047
  • ▲
    Executives
    0DART
    1,000 sharesShareKRXDART:20260624000118
    Canonical exit: 21 Sept 2026 (T+90)
  • ▲
    Executives
    0DART
    2,000 sharesShareKRXDART:20260609000065
    Canonical exit: 2 Sept 2026 (T+90)
  • ▲
    Executives
    17M KRW10DART
    1,000 shares@ ₩17,470.00100.0% of flowShareKRXDART:20260601000073
    Canonical exit: 20 Aug 2026 (T+90)
  • ▲
    Executives
    0DART
    1,000 sharesShareKRXDART:20260108000018
    Canonical exit: 2 Apr 2026 (T+90)
  • ▲
    Executives
    0DART
    1,000 sharesShareKRXDART:20251219000157
    Canonical exit: 16 Mar 2026 (T+90)
  • ▼
    대량보유자Executives
    0DART
    137,723 sharesKRXDART:20251031000370
  • ▼
    Executives
    0DART
    21,034 sharesShareKRXDART:20250925000624
  • ▼
    대량보유자Executives
    0DART
    5,693 sharesKRXDART:20250804000222
  • ▲
    대량보유자Executives
    0DART
    6,000 sharesKRXDART:20250609000091
    Canonical exit: 27 Aug 2025 (T+90)
  • ▲
    Executives
    0DART
    6,000 sharesShareKRXDART:20250528000057
    Canonical exit: 10 Apr 2025 (T+90)
  • ▲
    Executives
    0DART
    1,000 sharesShareKRXDART:20250110000216
    Canonical exit: 6 Apr 2025 (T+90)
  • ▲
    대량보유자Executives
    0DART
    2,206,329 sharesKRXDART:20250108000063
    Canonical exit: 23 Mar 2025 (T+90)
  • ▲
    대량보유자Executives
    0DART
    2,206,329 sharesKRXDART:20250107000462
    Canonical exit: 23 Mar 2025 (T+90)
  • ▲
    대표이사(사장)Executives
    0DART
    ShareKRXDART:20241206000112
    Canonical exit: 2 Mar 2025 (T+90)
  • ▲
    감사Executives
    0DART
    ShareKRXDART:20241108000408
    Canonical exit: 4 Feb 2025 (T+90)
  • ▼
    Executives
    0DART
    197,164 sharesKRXDART:20241108000406
  • ▲
    대표이사(사장)Executives
    0DART
    ShareKRXDART:20240913000076
    Canonical exit: 4 Dec 2024 (T+90)
  • ▲
    대표이사(사장)Executives
    0DART
    ShareKRXDART:20240820000068
    Canonical exit: 11 Nov 2024 (T+90)
  • ▲
    부사장Executives
    0DART
    ShareKRXDART:20240809000164
    Canonical exit: 5 Nov 2024 (T+90)
  • ▼
    감사Executives
    0DART
    ShareKRXDART:20240718000271
  • ▲
    대표이사(사장)Executives
    0DART
    ShareKRXDART:20240613000052
    Canonical exit: 2 Sept 2024 (T+90)

25 of 75 declarations

About i-SENS, Inc.

아이센스 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative technologies and solutions for the medical field.